Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study
Figure 3
Hazard ratio estimates over time. The plain line shows the hazard ratio estimate (logarithmic scale) over time (in months) for DMFS (a) and OS (b), together with the 95% confidence interval (hashed lines). The vertical line is set at 36 months for DMFS and 48 months for OS. Circles show Schoenfeld’s residuals.
